Jubilant Life Sciences Q2 net up 8%

Integrated pharmaceutical and life sciences company Jubilant Life Sciences Ltd, has posted consolidated net profit of Rs 79 crore for the second quarter ended September, an 8% increase over last year, after accounting for Rs 43 crore mainly due to unrealised foreign exchange loss in the quarter.

Integrated pharmaceutical and life sciences company Jubilant Life Sciences Ltd, has posted consolidated net profit of Rs 79 crore for the second quarter ended September, an 8% increase over last year, after accounting for Rs 43 crore mainly due to unrealised foreign exchange loss in the quarter.

HT Image

Revenue during the quarter was at Rs 1,048 crore, up 22%. The international business from 75 countries contributed 70% to sales at R730 crore.

Commenting on the company’s performance, Shyam S Bhartia, chairman and managing director and Hari S Bhartia, co-chairman and managing director, Jubilant Life Sciences said: “We are happy to share that the company has delivered strong revenue and earnings growth in the second quarter of this year as well as for the first half year.”